Agenus Inc.
Symbol: AGEN (NASDAQ)
4.44
▲ (0.34%) 0.015
Company Description:
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
Key Stats
- Today's Open: $4.42
- Today's High: $4.529
- Today's Low: $4.131
- Today's Volume: 273.13K
- Yesterday Close: $4.42
- Yesterday High: $4.5999
- Yesterday Low: $3.9486
- Yesterday Volume: 928.07K
- Last Min Volume: 1.32K
- Last Min High: $4.41
- Last Min Low: $4.41
- Last Min VWAP: $4.41
Company Profile
- Name: Agenus Inc.
- Website: https://www.agenusbio.com
- Listed Date: 2000-02-04
- Location: LEXINGTON, MA
- Market Status: Active
- CIK Number: 0001098972
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $140.84M
- Round Lot: 100
- Outstanding Shares: 31.86M
- Asset Type: CS
RECENT FILINGS FOR AGEN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-09 | 8-K | View |
| 2025-10-06 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-09-23 | 8-K | View |
| 2025-09-23 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-26 | 4 | View |
| 2025-08-12 | S-8 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 4 | View |
| 2025-08-11 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-28 | 4 | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-07-15 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-30 | 4 | View |
Latest News on AGEN